𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of sodium iodide symporter expression in differentiated thyroid carcinomas

✍ Scribed by Elaine C. Morari; Marjory A. Marcello; Ana Carolina T. Guilhen; Lucas L. Cunha; Paulo Latuff; Fernando A. Soares; José Vassallo; Laura S. Ward

Book ID
108704895
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
307 KB
Volume
75
Category
Article
ISSN
0300-0664

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endogenous expression of the sodium iodi
Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma
✍ Florian C. Gaertner; Franziska Rohde; Jan Mueller; Birgit Blechert; Klaus-Peter 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 304 KB 👁 1 views

## Abstract The sodium iodide symporter (NIS) mediates iodide uptake into the thyroid. Because of this mechanism, differentiated thyroid cancer is susceptible for radioiodine therapy. Functional NIS expression in extrathyroidal tumors has been reported mainly in breast cancer. We screened colorecta

Reciprocal immunohistochemical expressio
Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis
✍ Young Ho Jung; J. Hun Hah; Myung-Whun Sung; Kwang Hyun Kim; Soo Youn Cho; Yoon K 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract ## Objectives/Hypothesis: Sodium/iodide symporter (NIS) is a glycoprotein which is related to the concentration of radioiodine in thyroid cancer. Glucose transporter‐1 (Glut‐1) and hexokinases (HK) are glycoproteins related to glucose metabolism (i.e., uptake and phosphorylation) in va

Genetically targeted radiotherapy of hea
Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS)
✍ Andrew W. Gaut; Gang Niu; Kimberly J. Krager; Michael M. Graham; Douglas K. Tras 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

## Abstract ## Background. Gene therapy that uses delivery of the sodium‐iodide symporter (NIS) gene followed by radioiodide administration has been proposed as a novel form of radiotherapy for nonthyroidal cancers. ## Methods. In vitro [^125^I] iodide accumulation and efflux from cells was dete